Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities.

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an emerging cancer of the immune system that is exclusively associated with textured-surface breast implants. This clinical review provides an update on the diagnosis and management of BIA-ALCL with an emphasis on major advances. The epidemiology and pathophysiology of the disease are also reviewed, focusing on current paradigm shifts and highlighting current controversies related to disease classification and risk mitigation. Finally, the authors conclude by discussing medicolegal and ethical issues surrounding BIA-ALCL while establishing a future basic science and clinical research agenda that is central to improving patient safety.
Competing Interests: Disclosure The authors have no associations or financial disclosures to report that create a conflict of interest with the information presented in this article.
(Copyright © 2020 Elsevier Inc. All rights reserved.)